🇺🇸 US Stock Screener ← Switch market ⚡ HerAI

XBIT XBIT

Company Profile ↓
$2.19
-21.33% 1Y
Mkt Cap$66.77M
P/E-1.47
P/B0.49
52W High$2.94
52W Low$2.12
Book Value$4.60
EPS (TTM)$-1.49

Company Overview

XBIT (XBIT) is a publicly traded company listed on with a market capitalization of $66.77M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.07.

Growth & Price Performance

Stock Price Performance

1 Year:-21.33%
6 Months:-4.57%
3 Months:-6.60%
1 Month:-4.57%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 9% of range
$2.12 $2.94
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)42.49 · Neutral
Price Performance
1M-4.57%
3M-6.60%
6M-4.57%
1Y-21.33%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Trading 25.3% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-1.47
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$4.60
Price to Book
0.49
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-
Earnings (YoY)
-

Profitability & Returns

ROCE
-39.17%
ROE
-32.45%
ROA
-30.34%
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.18
EPS (TTM)
$-1.49

Balance Sheet & Liquidity

Debt/Equity
0.07
Quick Ratio
-
Current Ratio
16.01
Debt
$10.25M
Total Assets
$139.84M
Current Assets
$117.05M
Working Capital
$119.02M

Ownership

Promoter Holding
24.33%
Chg in Prom Hold
-
FII / Inst Holding
6.73%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$66.77M
Total Revenue (TTM)
$0
EBITDA
$-43.53M
Free Cash Flow
$-40.21M
Operating Cash Flow
$-39.92M
Shares Outstanding
30.49M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ------------0-0-12.68M15.50M10.55M-4.85M4.53M4.52M-500.00K1.53M1.68M-000----00000
Cost of Revenue ----------------------------------------
Gross Profit -------------00-3.01M2.30M1.12M-2.55M3.17M3.41M-287.00K1.32M1.47M-000---------
Operating Expenses -----------------------------------13.55M6.34M6.05M29.75M6.27M
Operating Income -10.25M-13.62M-12.46M-16.44M-10.27M-9.69M-6.59M-7.51M-4.15M-5.62M-5.12M-6.11M-5.80M-6.01M-6.11M-13.31M-2.17M-6.51M-4.67M-4.92M-3.55M-10.61M-3.73M-7.19M-7.84M-12.09M-6.39M-8.16M-7.14M-13.26M-8.52M-8.59M-10.85M-14.97M-7.90M-13.55M-6.34M-6.05M-29.75M-6.27M
EBITDA ------------------------------------10.32M-1.29M-5.48M-26.44M-5.12M
Interest Expense -----------------------------------88.00K0000
Pretax Income ------------------------------------10.86M-1.73M-5.91M-26.82M-5.46M
Tax Provision -----------------------------------29.00K28.00K102.00K76.00K49.00K
Net Income -10.26M-13.62M-12.48M-16.40M-10.56M-9.13M-6.21M-7.25M-4.07M-5.91M-5.05M-6.11M-5.86M-5.85M-6.15M686.50M-14.00K-6.84M-2.53M-1.84M-2.57M-5.12M-3.26M-6.47M-5.39M-11.64M-12.66M-3.20M-3.82M-8.74M-7.36M-4.63M-10.00M-13.01M-5.01M-10.88M-1.76M-6.01M-26.89M-5.50M
Diluted EPS -------------0.16-0.16-0.1514.82--------------------0.36-0.06-0.20--0.18
R&D Expense 7.81M11.22M9.77M-8.19M7.40M4.93M-2.99M3.95M3.94M-4.53M4.69M4.53M-1.16M2.56M2.35M-4.63M9.25M5.60M-6.82M10.39M7.01M-6.23M11.27M7.55M-9.82M12.98M7.13M11.62M5.34M5.08M-5.21M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -----0044.00M-4.01M000
Cost of Revenue --------5.82M651.00K0--
Gross Profit -----009.45M12.57M3.36M0--
Operating Expenses ---------37.85M37.51M42.47M55.69M
Operating Income -9.93M-21.78M-37.51M-52.76M-34.06M-20.99M-31.23M-18.28M--34.49M-37.51M-42.47M-55.69M
EBITDA ----------31.88M-22.57M-36.01M-43.53M
Interest Expense ----------0807.00K88.00K
Pretax Income ----------33.59M-24.31M-38.56M-45.30M
Tax Provision ----------688.00K244.00K-32.00K235.00K
Net Income -9.93M-21.72M-37.48M-52.76M-33.15M-21.14M668.63M-11.22M--32.90M-24.56M-38.53M-45.54M
Diluted EPS -----0.95-0.5914.44-0.36--1.08-0.81-1.26-1.49
R&D Expense 7.93M14.33M31.31M42.49M26.42M15.72M24.09M9.53M28.27M31.54M32.85M37.76M47.39M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --62.18M109.36M67.05M62.97M44.34M816.88M353.74M-246.10M226.62M199.09M150.08M
Current Assets ----------219.84M201.72M174.57M126.95M
Cash & Equivalents 4.17M7.24M57.33M91.05M34.32M31.77M15.82M714.59M237.37M-157.31M200.02M172.68M125.55M
Inventory --------------
Receivables ---------0----
Total Liabilities --3.15M6.31M7.99M2.81M2.95M61.25M5.11M-5.70M7.77M16.82M9.73M
Current Liabilities --3.15M6.29M7.96M2.79M2.94M60.19M3.98M-4.07M6.10M15.11M7.93M
Long Term Debt --------------
Total Debt ------------10.25M-
Total Equity 7.37M10.23M59.03M103.05M59.06M60.16M41.40M755.63M348.64M-240.40M218.85M182.27M140.35M
Shares Outstanding ----------30.44M30.44M30.49M30.49M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -8.91M-11.70M-33.31M-46.02M-33.65M-16.54M-18.27M-65.15M--14.82M-18.73M-30.96M-39.92M
Investing Cash Flow -59.00K-1.40M-10.39M-13.91M-1.41M-122.00K674.80M-3.73M--63.89M61.50M-1.30M-289.00K
Financing Cash Flow 12.04M63.20M77.47M2.94M33.32M201.00K42.10M-409.72M-0-9.00K10.45M-10.25M
Capital Expenditure -59.00K-1.40M-2.32M-4.75M-1.41M-122.00K-204.00K-3.73M--585.00K-362.00K-1.30M-289.00K
Free Cash Flow -8.97M-13.10M-35.63M-50.76M-35.05M-16.66M-18.47M-68.88M--15.41M-19.09M-32.27M-40.21M
Net Change in Cash ----------78.72M42.76M-21.82M-50.46M
Share Buybacks ---------014.00K0-
Dividends Paid ------0075.00M0---

Ratios (Annual)

Figures in %.

Metric Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -------21.5%-83.8%---
Operating Margin % --------41.5%--860.1%---
Net Margin % --------25.5%--820.4%---
ROE % -97.1%-36.8%-36.4%-89.3%-55.1%-51.1%88.5%-3.2%--13.7%-11.2%-21.1%-32.4%
ROCE % --36.9%-36.4%-89.3%-56.6%-50.7%-4.1%-5.2%--14.2%-17.0%-23.1%-39.2%

Shareholding Pattern

Insiders
24.33%
Institutions
6.73%
Public Float
8.90%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 1.05% 321.15K $729.00K
2 Geode Capital Management, LLC 0.70% 214.12K $486.04K
3 Vanguard Capital Management LLC 0.66% 200.18K $454.41K
4 RBF Capital, LLC 0.65% 198.50K $450.60K
5 Morgan Stanley 0.49% 147.88K $335.69K
6 Bridgeway Capital Management, LLC 0.32% 98.45K $223.47K
7 Vanguard Fiduciary Trust Co 0.30% 92.36K $209.67K
8 Millennium Management Llc 0.26% 79.33K $180.08K
9 State Street Corporation 0.24% 73.01K $165.72K
10 Northern Trust Corporation 0.22% 66.26K $150.41K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for XBIT

Yahoo Finance Mon, 15 Jun 2026

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today announced that its Investigat…

Yahoo Finance Fri, 19 Dec 2025

3 Promising Penny Stocks With Market Caps Over $30M

Major stock indexes in the United States have recently experienced a surge, driven by gains in technology shares and positive economic indicators. While the term "penny stocks" might seem outdated, it still refers to shares of smaller or ne…

Yahoo Finance Wed, 12 Nov 2025

November 2025's Promising Penny Stocks To Watch

As the Dow Jones Industrial Average reaches an all-time high amid optimism over the potential end of a prolonged U.S. government shutdown, investors are keenly observing market dynamics and seeking opportunities across various sectors. Penn…

XBIT — Frequently Asked Questions

What is the current share price of XBIT?

As of 2026-09-16 18:39 PDT, XBIT trades at $2.19 on NASDAQ/NYSE. Its 52-week range is $2.12 to $2.94.

What is the market capitalisation of XBIT?

XBIT has a market capitalisation of $66.77M on NASDAQ/NYSE.

What is the P/E ratio of XBIT?

XBIT trades at a trailing price-to-earnings (P/E) ratio of -1.47. Its price-to-book (P/B) ratio is 0.49.

What is the return on equity (ROE) of XBIT?

XBIT has a return on equity (ROE) of -32.45%. Its return on capital employed (ROCE) is -39.17%.

Is XBIT a good stock to buy?

This page provides a data-driven analysis of XBIT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space